Chewy shares surge after earnings beat on top and bottom lines

Chewy shares surge after earnings beat on top and bottom lines


A dog sits in front of the New York Stock Exchange during Chewy Inc.’s initial public offering, June 14, 2019.

Michael Nagle | Bloomberg | Getty Images

Shares of Chewy surged more than 13% in extended trading Wednesday after the pet retailer posted earnings that beat Wall Street’s estimates.

Here’s how the digital retailer did in its fiscal first quarter compared with what Wall Street was anticipating, based on a survey of analysts by Refinitiv:

  • Earnings per share: 5 cents, versus a loss of 4 cents a share expected
  • Revenue: $2.78 billion, versus $2.73 billion expected

The company’s reported net income for the three-month period that ended April 30 was $22.18 million, or 5 cents a share, compared with $18.47 million, or 4 cents a share, a year earlier.

Sales rose to $2.78 billion, up 14.7% from $2.43 billion a year earlier.

Net sales per active customer and sales from autoship customers reached record highs in the quarter, Chewy said in a press release.

Gross margins were up about 1 percentage point.

The earnings beat comes after the retailer posted its first annual profit at the close of fiscal 2022 earlier this year, but noted the pet industry was seeing softness in discretionary and hard goods categories, which carry higher margins than consumables such as pet food.



Source

Forgotten no more: Generation X is driving beauty sales
Business

Forgotten no more: Generation X is driving beauty sales

Ryan Mckeever | E+ | Getty Images Move over, Sephora kids. While younger generations have been buying beauty products in droves, data shows that a different generation holds more spending power: Generation X. Often dubbed the “forgotten generation,” Gen X spans those born between 1965 and 1980, according to Pew Research Center. Sandwiched between baby […]

Read More
FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More